rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Bliss GVS Pharma Ltd.

506197 BLISSGVS Group (B)

01 Oct,15:29
133.45
1.95 (1.48%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Bliss GVS Pharma Ltd.

BUYSELL

81,904 131.50 134.70 - 130.50 148.95 - 77.65 1,402.56
NSE | BSE

Bliss GVS Pharma Ltd.

BLISSGVS

01 Oct,15:52
133.32
1.75 (1.33%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Bliss GVS Pharma Ltd.

BUYSELL

603,940 131.57 135.00 - 130.60 149.60 - 77.35 806.08
(Rs. Crore)

Financial Results of Bliss GVS Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales605.46598.34636.36465.51441.95
Operating profit107.1790.16109.2091.46100.17
Interest5.8110.064.324.194.56
Gross profit134.86130.87137.50104.95130.54
EPS (Rs)4.848.218.946.548.95

See more in Research Center »

About Bliss GVS Pharma Ltd.

Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others. Wikipedia

News for Pharmaceuticals and health care

BP to Continue...
BP to Continue Oil & Gas Ventures with Reliance in India
BP's exclusivity with Reliance Industries has ended but the energy giant will continue to pursue oil and gas ventures with the Mukesh Ambani firm in India.
Oct 02, 2024 12:58
Bombay Stock...
Bombay Stock Exchange Brokers' Forum Appoints New Chairman
The Bombay Stock Exchange Brokers' Forum (BBF) has appointed Anup Gupta as its new chairman, succeeding Kishor Kansagra. Gupta brings extensive financial expertise to the role.
Oct 02, 2024 12:44
Royal Enfield...
Royal Enfield Sales Surge 11% in September
Royal Enfield's wholesales rose 11% to 86,978 units in September, driven by strong domestic demand and new model launches.
Oct 02, 2024 12:34
Jubilant Agro...
Jubilant Agro Sciences Inks Pact for Agro Intermediate Production
Jubilant Agro Sciences has partnered with a leading agrochemical company to produce an agro intermediate, expected to generate over USD 300 million in revenue over the next few years.
Oct 02, 2024 12:16
Real Estate...
Real Estate Investment Soars 45% in Q3 2024: Colliers
Institutional investments in Indian real estate surged to USD 1.15 billion in July-September, driven by strong demand for premium homes and offices. Colliers reports office segment attracting USD...
Oct 02, 2024 11:02

More News »

Top News

BP to Continue...
BP to Continue Oil & Gas Ventures with Reliance in India
BP's exclusivity with Reliance Industries has ended but the energy giant will continue to pursue oil and gas ventures with the Mukesh Ambani firm in India.
Oct 02, 2024 12:58
Bombay Stock...
Bombay Stock Exchange Brokers' Forum Appoints New Chairman
The Bombay Stock Exchange Brokers' Forum (BBF) has appointed Anup Gupta as its new chairman, succeeding Kishor Kansagra. Gupta brings extensive financial expertise to the role.
Oct 02, 2024 12:44
Royal Enfield...
Royal Enfield Sales Surge 11% in September
Royal Enfield's wholesales rose 11% to 86,978 units in September, driven by strong domestic demand and new model launches.
Oct 02, 2024 12:34
Jubilant Agro...
Jubilant Agro Sciences Inks Pact for Agro Intermediate Production
Jubilant Agro Sciences has partnered with a leading agrochemical company to produce an agro intermediate, expected to generate over USD 300 million in revenue over the next few years.
Oct 02, 2024 12:16
Singapore's Role in Bengaluru's Tech Hub Development
Singapore has been a key partner in Bengaluru's tech growth over the past 30 years, fostering innovation and attracting global talent. Learn about their collaboration at the Bengaluru Tech Summit...
Oct 02, 2024 11:51

More Top News »

Report Card

PE Ratios
27.59
EPS (Rs.)
4.84
Sales (Rs. Cr)
148.96
Face Value (Rs.)
1
Net Profit Margin (%)
8.36
Last Bonus
3:5
Last Dividend(%)
50
Return on Average Equity
5.12

BSE Announcements from Bliss GVS Pharma Ltd. (See all)

announcement Closure of Trading Window - 2 day(s) ago
announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 18 Sep 2024

Compare 'Bliss GVS Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,926.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,757.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,068.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,195.75
  • Compare
  • Max Healthcare Institute Ltd.
  • 985.45
  • Compare
  • Alkem Laboratories Ltd.
  • 6,060.90
  • Compare
  • Divi's Laboratories Ltd.
  • 5,446.20
  • Compare

Most Active

  • Change (Rs.)
  •  

Bliss GVS Pharma Ltd. performance snapshot

If you had invested Rs.  in Bliss GVS Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Bliss GVS Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Bliss GVS Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close